INTERNATIONAL JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-09-04 Leopard FD

审稿速度:1.0 | 投稿命中率:5.0
经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了

143 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-08-09 1831f8cce8m

你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表::
有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表:
有回复了吗?

188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?

223 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-08-09 1831f8cce8m

怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表::
请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表:
请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样

139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样

253 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-08-08 zzu

二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表:
最近文章发的手软
We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!

OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软
We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!

209 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-08-04 hongshd

这么牛逼 OnJuly20th 2018-06-07 发表::
最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表:
最近文章发的手软
We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!

OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!

257 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-07-27 zzu

请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表:
209 days, from manu*******submission to acceptance.

Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance.

244 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-07-23 二氧化硫

请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！

226 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-06-28 Dr. H

209 days, from manu*******submission to acceptance.

233 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-06-27 希望SCI不是梦

请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表::
回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表:
回复了.大修

134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修

305 0

[GetPortalCommentsPageByObjectIdResponse(id=560720, encodeId=a604560e2047, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这个杂志一个月就能收到400篇稿件，一年接近5000篇，但是只发表400篇文章，大家可以算算接受率有多少……越来越难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Tue Sep 04 00:00:00 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559966, encodeId=5a35559966d0, content=你的怎么样了，revise 了吗188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559965, encodeId=6c2355996531, content=怎么样送审了吗139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样希望SCI不是梦 2018-06-27 00:00:00 发表: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, beContent=139GF963193(暂无昵称) 2018-06-27 发表:: 请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04502111801, createdName=1831f8cce8m, createdTime=Thu Aug 09 00:00:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559949, encodeId=257e55994930, content=二审回来awaiting decision已经15天了，怎么回事呢，怎么这么慢呢？？OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Wed Aug 08 00:00:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559846, encodeId=b97b5598461e, content=这么牛逼 OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!OnJuly20th 2018-06-07 22:04:00 发表: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, beContent=OnJuly20th 2018-06-07 发表:: 最近文章发的手软 We are pleased to inform you that your paper entitled "***" has been accepted for publication as a "Research Article" in the category "Molecular Cancer Biology" of the International Journal of Cancer. Congratulations!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e29e81875, createdName=hongshd, createdTime=Sat Aug 04 00:00:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559598, encodeId=f2aa559598a9, content=请问这个杂志awaiting decision一般多久啊？？我的一申回来这个状态已经4天了，怎么还没意见啊Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., beContent=Dr. H 2018-06-28 00:00:00 发表: 209 days, from manu*******submission to acceptance., objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd031604266, createdName=zzu, createdTime=Fri Jul 27 00:00:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559504, encodeId=ccf6559504a1, content=请问下投稿后生成的PDF文件里面没有补充材料的下载链接正常吗？感觉以前投稿的时候，补充材料虽然看不到，但都会有个下载链接，这个杂志生成的PDF好像就没有补充材料这回事一样，求大神解答一下，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=88fc2326384, createdName=二氧化硫, createdTime=Mon Jul 23 22:56:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558600, encodeId=3afc55860031, content=209 days, from manu*******submission to acceptance., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558499, encodeId=b4b555849914, content=请问这个杂志是一投就under review了么?周一投.周三显示under review,但看前面有战友说和别的杂志的under review意义不一样134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修134****1281(暂无匿称) 2018-06-26 00:00:00 发表: 回复了.大修, beContent=134****1281(暂无匿称) 2018-06-26 发表:: 回复了.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5312297237, createdName=希望SCI不是梦, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558355, encodeId=e6d3558355cc, content=回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表: 有回复了吗?, beContent=188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cd32009791, createdName=1e1e8ec1m81(暂无匿称), createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=)]

2018-06-26 1e1e8ec1m81(暂无匿称)

回复了.大修188gOXZ1799(暂无昵称) 2018-06-21 发表::
有回复了吗?188gOXZ1799(暂无昵称) 2018-06-21 00:00:00 发表:
有回复了吗?

188gOXZ1799(暂无昵称) 2018-06-21 发表:: 有回复了吗?

266 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务